Recent News

By Category: Agents & Toxins

The bacteria-fighting super element that’s making a comeback in hospitals: copper

(Washington Post)- Ancient Egyptians used copper to sterilize chest wounds and drinking water. Greeks, Romans and Aztecs relied on copper compounds to treat burns, headaches and ear infections. Thousands of years later, the ancient therapeutic is being embraced by some hospitals because of its ability to kill bacteria and other microbes on contact, which can Read More »

September 21, 2015
| Filed under North America, Agents & Toxins, and Public Health
Share

BAA – Medical Countermeasures for Priority Pathogens

(Global Biodefense) The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development of therapeutic products for use in post-event settings following the intentional release or natural outbreak of high priority biological threats. Countermeasures are sought for Ebola and other filoviruses, Clostridium botulinum, Yersinia pestis, Francisella Read More »

July 16, 2015
| Filed under Agents & Toxins and Countermeasures
Share

Improved Nerve Agent Treatment System

The U.S. Department of Defense (DoD) is conducting market research on manufacturing capabilities for the nerve agent antidote scopolamine for intramuscular administration.

April 9, 2015
| Filed under Agents & Toxins and Countermeasures
Share

Technologies for Host Resilience (THoR)

The Defense Advanced Research Projects Agency (DARPA) has announced a new Technologies for Host Resilience (THoR) Broad Agency Announcement (BAA) to catalyze the development of breakthrough interventions that would increase the ability of patients’ own bodies to tolerate a broad range of pathogens.

April 9, 2015
| Filed under Agents & Toxins and Countermeasures
Share

RFI – Diagnostic Devices for Biological, Chemical and Nuclear Threats

The Joint Project Management Medical Countermeasure Systems (JPM-MCS), as part of the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), has issued a Request For Information (RFI) for the advanced development, procurement, fielding, and sustainment of medical treatment, prophylactic, and diagnostic capabilities against chemical, biological, radiological, and nuclear (CBRN) warfare agents.